Sociedad Americana de Hirudoterapia

Long-Term Outcome after Successful Lower Extremity Free Flap Salvage.

Research article published in Journal of reconstructive microsurgery (2018)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosBigdeli et al. · Journal of reconstructive microsurgery, 2018

Abstract

BACKGROUND:  Vascular occlusion after free flap surgery has become a rare complication but still poses a major challenge. It necessitates urgent re-exploration, but the logistic challenge to provide sufficient resources for the emergency intervention remains. The aim of this study was to analyze the long-term outcome after successful lower extremity free flap salvage. METHODS:  A single-center retrospective study including long-term follow-up was approved by the local ethics committee. From January 1999 to December 2010, a total of 581 free flaps were performed for lower extremity reconstruction. Eighty-six flaps required emergency re-exploration, of which 65 could be salvaged. Fifteen salvaged flaps were excluded from the study because of secondary amputation. Of 50 patients, 29 (6 females and 23 males) were eligible for follow-up. The mean follow-up time was 54.5 ± 32.9 months. Health-related quality of life (Short Form 36 [SF-36]) and scar quality (Vancouver Scar Scale [VSS]) were analyzed. RESULTS:  The overall flap survival rate was 94.7% and the total loss rate was 5.3%. The re-exploration rate was 14.8% (86 of 581 flaps). The salvage rate was 75.6% (65 of 86 flaps). Twenty-one free flaps were totally lost (24.4%). Partial flap loss occurred in 12 cases (14.0%); 67.5% of the vascular complications occurred during the first 24 hours, 20.9% between 24 and 72 hours, and 11.6% after more than 72 hours. The mean time from the first signs of impaired flap perfusion to re-exploration was 1.3 ± 0.4 hours, and from free tissue transfer to re-exploration was 16.2 ± 1.9 hours. The overall scar appearance was good with an average VSS score of 4.0 points. The average SF-36 physical component score was 54.4 ± 5.4 and the mental component score was 63.1 ± 10.7. CONCLUSION:  Careful monitoring and the opportunity for urgent re-exploration are the key to success for free flaps salvage. Following these principles, an acceptable long-term outcome can be achieved.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdolescentAdultAgedFemaleFollow-Up StudiesFree Tissue FlapsGraft RejectionHumansLimb SalvageLower ExtremityMaleMicrosurgery

Resumen

Vascular occlusion after free flap surgery has become a rare complication but still poses a major challenge. It necessitates urgent re-exploration, but the logistic challenge to provide sufficient resources for the emergency intervention remains.

Por qué esto importa para la hirudoterapia

Este estudio analizó los resultados a largo plazo y las tasas de éxito del rescate de colgajos libres de extremidades inferiores tras oclusión vascular, enfatizando la importancia de una monitorización cuidadosa y de la reexploración urgente. El rescate de colgajos libres comprometidos es directamente relevante para la hirudoterapia, ya que las sanguijuelas medicinales son una herramienta ampliamente reconocida para tratar la congestión venosa en colgajos en fallo. Comprender el cronograma, la urgencia y el éxito de los procedimientos de rescate de colgajos proporciona un contexto valioso para los nichos quirúrgicos donde se aplica la terapia con sanguijuelas. Sin embargo, el resumen no menciona las sanguijuelas ni la terapia con sanguijuelas, lo que hace que la conexión sea indirecta.

Citación

Long-Term Outcome after Successful Lower Extremity Free Flap Salvage.

Bigdeli et al. · Journal of reconstructive microsurgery, 2018

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.